|
|||||
|
Date: Wednesday, October 03, 2012 - 9:00 am
|
||||
|
|||||
|
SMi proudly present their 4th annual 'Partnerships with CROs' Conference 3rd and 4th October 2012, Central London.
For information on sponsorship and exhibition opportunities, Contact our Sponsorship Department
Last year's attendees included representatives from:
Partnerships with CROs Conference 2011 testimonials:
“Interesting comments on panel discussion”
“Excellent, just what this industry needs”
“Good examples, thought provoking." “Excellent questions and moderating“
Why should you attend this event? Discuss the strategic rationale for clinical development outsourcing among the large pharmaceutical companies. Network and discuss ideas with key decision makers in pharma / biotech / CROs. Hear from industry experts about the current issues with CRO partnership. Learn what clinical development capabilities do various companies consider core and noncore, and how is this changing Investigate to what extent is the design of relationships and associated capabilities aligned with strategic intent Develop stratergy in relationship structure; standard contract, sophisticated strategic alliance - or something in between.
Tim Highman, Director Outsourcing, Pfizer
Andrew Huxley, Outsourcing Director, Eli Lilly & Co
Gareth Lewis, Director Clinical Research, Pfizer
Prasad Velisetty, Senior Medical Director, Quintiles
Domonic Bowers, Associate Medical Director, Quintiles
Gary Reeves, Clinical Contracts Manager, Biogen Idec
Graeme Ladds, Director, PharSafer
Albert Agro, President, HNZ-Strategy
John Bennett, Director, JABPharma
Volker Ronicke, Vice President, Booz & Co
Peter Behner, Consultant, Booz & Co
Clare Morgan, Director of Industry, NIHR Clinical Research Network Coordinating Centre
Janet Wisely, Chief Executiv, Health Research Authority
Two confirmed half day workshops
Volker Ronicke Vice President & Peter Behner, Consultant, Booz & Co
Graeme Ladds, Director, PharSafer |
|||||